NeoTherapeutics’ Quarter Loss: $5.3 Million
NeoTherapeutics Inc., an Irvine drug development company, reported a net loss of $5.3 million, or 70 cents a share, for the third quarter, compared with a net loss of $3 million, or 54 cents a share, for the 1998 third quarter. No revenue was recorded.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
